Cargando…
Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo
BACKGROUND: Epigenetic code modifications by histone deacetylase inhibitors (HDACi) have been proposed as potential new therapies for lymphoid malignancies. Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive lymphoma for which standard first line treatment is the chemotherap...
Autores principales: | Damm, Jesper Kofoed, Gordon, Sandra, Ehinger, Mats, Jerkeman, Mats, Gullberg, Urban, Hultquist, Anne, Drott, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429466/ https://www.ncbi.nlm.nih.gov/pubmed/25973343 http://dx.doi.org/10.1186/2162-3619-4-4 |
Ejemplares similares
-
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
por: Scialdone, Annarita, et al.
Publicado: (2017) -
Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma
por: Kalliara, Eirini, et al.
Publicado: (2023) -
PREVENT: Assessing and Improving Knowledge of the Sodium Valproate Pregnancy Prevention Programme in Psychiatric Prescribing
por: Havens, Laura
Publicado: (2022) -
ZBED6 binding motifs correlate with endogenous retroviruses and Syncytin genes
por: Pettersson, Mats E, et al.
Publicado: (2020) -
Physiologically relevant culture medium Plasmax improves human placental trophoblast stem cell function
por: Avellino, Giulia, et al.
Publicado: (2023)